최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Antiviral research, v.143, 2017년, pp.134 - 141
Usharani, J. , Park, S.Y. , Cho, E.J. , Kim, C. , Ko, Y.J. , Tark, D. , Kim, S.M. , Park, J.H. , Lee, K.N. , Lee, M.H. , Lee, H.S.
Foot-and-mouth disease (FMD) is an economically important disease in most parts of the world and new therapeutic agents are needed to protect the animals before vaccination can trigger the host immune response. Although several interferons have been used for their antiviral activities against Foot-a...
J. Interferon Cytokine Res. Alexenko 19 1335 1999 10.1089/107999099312795 The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential
Am. J. Vet. Res. Cummins 66 164 2005 10.2460/ajvr.2005.66.164 Systemic effects of interferons after oral administration in animals and humans
J. Acquir Immune Defic. Syndr. Hum. Retrovirol. Dereuddre-Bosquet 11 241 1996 10.1097/00042560-199603010-00004 Anti-HIV potential of a new interferon, interferon-tau (trophoblastin)
Virology Diaz-San Segundo 413 283 2011 10.1016/j.virol.2011.02.023 Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
Virus Res. Domingo 91 47 2003 10.1016/S0168-1702(02)00259-9 Evolution of foot-and-mouth disease virus
Clin. Microbiol. Rev. Grubman 17 465 2004 10.1128/CMR.17.2.465-493.2004 Foot-and-mouth disease
J. Interferon Cytokine Res. Johnson 19 1107 1999 10.1089/107999099313046 IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression
J. Gen. Virol. Juste 81 525 2000 10.1099/0022-1317-81-2-525 Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease
Antivir. Res. Kim 104 52 2014 10.1016/j.antiviral.2014.01.014 A recombinant adenovirus bicistronically expressing porcine interferon-alpha and interferon-gamma enhances antiviral effects against foot-and-mouth disease virus
J. Clin. Microbiol. LaRocco 51 1714 2013 10.1128/JCM.03370-12 A continuous bovine kidney cell line constitutively expressing bovine alphavbeta6 integrin has increased susceptibility to foot-and-mouth disease virus
Methods Livak 25 402 2001 10.1006/meth.2001.1262 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
Biochimie Martal 80 755 1998 10.1016/S0300-9084(99)80029-7 IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities
J. Virol. Moraes 81 7124 2007 10.1128/JVI.02775-06 Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons
J. Interferon Cytokine Res. Nakajima 22 397 2002 10.1089/107999002753675839 Induction of blood 2',5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau
Endocrinology Oliveira 149 1252 2008 10.1210/en.2007-0863 Expression of interferon (IFN)-stimulated genes in extrauterine tissues during early pregnancy in sheep is the consequence of endocrine IFN-tau release from the uterine vein
Biol. Reprod. Ott 57 621 1997 10.1095/biolreprod57.3.621 Effects of exogenous recombinant ovine interferon tau on circulating concentrations of progesterone, cortisol, luteinizing hormone, and antiviral activity; interestrous interval; rectal temperature; and uterine response to oxytocin in cyclic ewes
Emerg. Infect. Dis. Park 19 655 2013 10.3201/eid1904.121320 Control of foot-and-mouth disease during 2010-2011 epidemic, South Korea
Nat. Rev. Immunol. Platanias 5 375 2005 10.1038/nri1604 Mechanisms of type-I- and type-II-interferon-mediated signalling
Cancer Res. Pontzer 51 5304 1991 Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1
J. Interferon Res. Pontzer 14 133 1994 10.1089/jir.1994.14.133 Structure/function studies with interferon tau: evidence for multiple active sites
Biochem. Biophys. Res. Commun. Pontzer 152 801 1988 10.1016/S0006-291X(88)80109-8 Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1
J. Immunol. Pontzer 158 4351 1997 10.4049/jimmunol.158.9.4351 Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau
Am. J. Hyg. Reed 27 493 1938 A simple method of estimating fifty per cent endpoints
J. Interferon Cytokine Res. Roberts 18 805 1998 10.1089/jir.1998.18.805 The evolution of the type I interferons
J. Virol. Rogez 77 12914 2003 10.1128/JVI.77.23.12914-12920.2003 Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines
Nat. Rev. Immunol. Sadler 8 559 2008 10.1038/nri2314 Interferon-inducible antiviral effectors
Clin. Microbiol. Rev. Samuel 14 778 2001 10.1128/CMR.14.4.778-809.2001 Antiviral actions of interferons
Rev. Sci. Tech. Scudamore 21 699 2002 10.20506/rst.21.3.1351 Control of foot and mouth disease: lessons from the experience of the outbreak in Great Britain in 2001
J. Immunol. Soos 155 2747 1995 10.4049/jimmunol.155.5.2747 The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity
Virology Zhu 404 32 2010 10.1016/j.virol.2010.04.021 Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.